John Trainer - 08 Apr 2021 Form 4 Insider Report for NexImmune, Inc. (NEXI)

Role
Chief Financial Officer
Signature
/s/ Ilse Johnson, Attorney-in-fact
Issuer symbol
NEXI
Transactions as of
08 Apr 2021
Transactions value $
$35,487
Form type
4
Filing time
19 May 2021, 16:16:13 UTC
Next filing
09 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NEXI Common Stock Options Exercise $17,743 +3,432 +7.14% $5.17* 51,474 08 Apr 2021 Direct
transaction NEXI Common Stock Options Exercise $17,743 +3,432 +6.67% $5.17* 54,906 08 May 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NEXI Stock Option (right to buy) Options Exercise $0 -3,432 -2.94% $0 113,245 08 Apr 2021 Common Stock 3,432 $5.17 Direct F1
transaction NEXI Stock Option (right to buy) Options Exercise $0 -3,432 -3.03% $0 109,813 08 May 2021 Common Stock 3,432 $5.17 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests as to 25% of the shares on January 8, 2021 with the remainder vesting in equal installments every month thereafter, beginning on January 8, 2021 and ending on January 8, 2024.